|
Market Closed -
NYSE
16:00:03 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 105.30 USD | -0.66% |
|
-2.86% | +31.38% |
| 09-17 | Haemonetics Shares Rise After Citigroup Upgrade | MT |
| 09-17 | Citigroup Upgrades Haemonetics to Buy From Neutral, Adjusts Price Target to $123 From $92 | MT |
| Market Cap | 4.79B 4.2B 3.97B 3.62B 6.77B 459B 6.82B 47.51B 18.4B 235B 17.99B 17.6B 754B | P/E 2027 * |
26.6x | P/E 2028 * | 23.4x |
|---|---|---|---|---|---|
| Enterprise Value | 5.45B 4.78B 4.52B 4.12B 7.71B 523B 7.76B 54.08B 20.95B 267B 20.47B 20.03B 858B | EV / Sales 2027 * |
3.85x | EV / Sales 2028 * | 3.42x |
| Free-Float |
98.74% | Yield 2027 * |
0.95% | Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| HAE | Delayed | |
CBOE
| HAE | Real-time | |
Deutsche Boerse AG
| HAZ | Delayed | |
Börse Stuttgart
| HAZ | Delayed | |
Boerse Muenchen
| HAZ | Real-time | |
Tradegate
| HAZ | Real-time |
Last Transcript: Haemonetics Corporation
| 1 day | -0.66% | ||
| 1 week | -2.86% | ||
| Current month | +2.16% | ||
| 1 month | -1.22% | ||
| 3 months | +36.24% | ||
| 6 months | +89.66% | ||
| Current year | +31.38% |
| 1 week | 104.71 | 110.28 | |
| 1 month | 100.53 | 110.45 | |
| Current year | 51 | 110.45 | |
| 1 year | 47.56 | 110.45 | |
| 3 years | 47.32 | 110.45 | |
| 5 years | 43.5 | 110.45 | |
| 10 years | 32.76 | 142.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 2016-05-15 | |
James D'Arecca
DFI | Director of Finance/CFO | 55 | 2022-04-10 |
Frank Chan
COO | Chief Operating Officer | 56 | 2025-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Kroll
BRD | Director/Board Member | 73 | 2005-12-31 |
| Director/Board Member | 62 | 2016-05-15 | |
Robert Abernathy
BRD | Director/Board Member | 71 | 2017-10-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/24/26 | Free | Director | 2,538 | 0.0056% | ||
| 7/24/26 | Free | Director | 2,538 | 0.0056% | ||
| 7/24/26 | Free | Director | 2,538 | 0.0056% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.66% | -2.86% | +118.60% | +19.33% | 4.79B | ||
| +0.22% | -1.29% | -24.16% | +5.26% | 175B | ||
| +0.97% | -3.79% | -5.92% | +12.27% | 113B | ||
| -0.95% | -0.60% | -0.03% | +65.22% | 58.57B | ||
| +2.56% | +1.59% | -0.42% | -29.55% | 50.07B | ||
| +1.49% | +3.89% | +15.12% | +53.65% | 49.92B | ||
| -0.97% | -3.06% | +29.09% | -2.26% | 32.69B | ||
| +0.12% | +9.67% | - | - | 30.44B | ||
| -0.85% | +2.24% | +41.65% | -1.32% | 26.07B | ||
| -1.58% | +7.22% | +23.81% | -6.14% | 23.55B | ||
| Average | +0.04% | +1.40% | +21.97% | +12.94% | 56.48B | |
| Weighted average by Cap. | +0.36% | -0.02% | -1.89% | +13.42% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 1.42B 1.24B 1.17B 1.07B 2B 136B 2.02B 14.05B 5.44B 69.38B 5.32B 5.2B 223B | 1.5B 1.31B 1.24B 1.13B 2.11B 143B 2.13B 14.83B 5.74B 73.22B 5.61B 5.49B 235B |
| Net income | 177M 156M 147M 134M 251M 17B 253M 1.76B 682M 8.69B 666M 652M 27.92B | 207M 182M 172M 157M 293M 19.86B 295M 2.06B 796M 10.15B 778M 761M 32.61B |
| Net Debt | 662M 581M 549M 500M 936M 63.45B 943M 6.57B 2.54B 32.42B 2.49B 2.43B 104B | 327M 287M 271M 247M 462M 31.35B 466M 3.24B 1.26B 16.02B 1.23B 1.2B 51.48B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-25 | US$105.30 | -0.66% | 492,604 |
| 26-09-24 | US$106.00 | -0.77% | 416,799 |
| 26-09-23 | US$106.82 | -1.57% | 704,878 |
| 26-09-22 | US$108.52 | -0.19% | 446,603 |
| 26-09-21 | US$108.73 | +0.30% | 327,026 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HAE Stock
Select your edition
All financial news and data tailored to specific country editions

















